Senior Research Nurse
I’ve been nursing for 18 years, the first half of my career spent in orthopaedic trauma and vascular surgery in the old Royal Infirmary of Edinburgh. It was a challenging and an enormous learning curve to say the least!
In 2006 I travelled the world working as a nurse in Australia to fund my adventure, and returned home to Scotland! I was lucky enough to gain employment within the emergency department in the Royal Infirmary of Edinburgh for around 9 years. During that time I got married, had two children, and worked in community nursing for a short while. Now I work on the staff bank in a variety of specialities but mainly within the emergency department and with the wonderful EMERGE research team.
I am new to research and I’m loving the challenges it brings, the vast amount there is yet to learn and being part of something that will have a positive influence on the delivery of patient care.
ETNA: Edinburgh Transient and Neurological attack: A Cohort Study
Patients frequently present with minor neurological symptoms where a diagnosis of transient ischaemic attack (TIA) or minor stroke is difficult to make positively or to exclude reasonably. For these patients, clinicians are uncertain whether they should: (a) reassure most patients that their symptoms are benign; (b) treat most patients with antiplatelet or other vascular prevention; or (c) stratify stroke risk further using clinical features or brain imaging.
This is important because clinical diagnosis is difficult. Mis-diagnosis is not infrequent and leads to harm from preventable recurrent stroke and costs to health systems from extra care and legal liabilities.
All ETNA participants will receive an MRI scan and the study aims to establish the feasibility and methods for a larger study of diagnostic utility of MR brain imaging and estimate the effects of MRI on clinician decision making.
This study has been recruiting in the Emergency Dept, inpatient wards and TIA clinics since August 2018. We aim to recruit 270 participants and have almost reached our target!
EHA - Epidemiological analysis for the Hereditary Angioedema Disease is an international, multicentre, epidemiological study that aims to explore the feasibility of a new Dried Blood Spot (DBS) filtercard-based screening algorithm and thereby the prevalence of the Hereditary Angioedema.
EHA - Epidemiological analysis for the Hereditary Angioedema Disease
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions